Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01055002Phase 2Completed
Phase 2, randomised trial in malaria comparing Artemether/lumefantrine tablets with Atovaquone/Proguanil HCl tablets (2 arms). Primary endpoint: Parasite clearance rates by PCR. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01055002.